| Symbol |
Name |
|
AAK1
|
AP2 associated kinase 1
|
|
ABI1
|
abl-interactor 1
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ACVR2A
|
activin A receptor, type IIA
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM28
|
ADAM metallopeptidase domain 28
|
|
ADAMTSL3
|
ADAMTS-like 3
|
|
ADGRG4
|
adhesion G protein-coupled receptor G4
|
|
AFF1
|
AF4/FMR2 family, member 1
|
|
AFF4
|
AF4/FMR2 family, member 4
|
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
|
AKAP9
|
A kinase (PRKA) anchor protein 9
|
|
ALPK2
|
alpha-kinase 2
|
|
ARFGEF1
|
ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited)
|
|
ARHGAP29
|
Rho GTPase activating protein 29
|
|
ARHGEF10
|
Rho guanine nucleotide exchange factor (GEF) 10
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ASPH
|
aspartate beta-hydroxylase
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP10A
|
ATPase, class V, type 10A
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKC
|
aurora kinase C
|
|
BAX
|
BCL2-associated X protein
|
|
BCL9
|
B-cell CLL/lymphoma 9
|
|
BCR
|
breakpoint cluster region
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRSK1
|
BR serine/threonine kinase 1
|
|
BTG1
|
B-cell translocation gene 1, anti-proliferative
|
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit
|
|
CAD
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
|
|
CAMK1D
|
calcium/calmodulin-dependent protein kinase ID
|
|
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta
|
|
CARS
|
cysteinyl-tRNA synthetase
|
|
CASC5
|
cancer susceptibility candidate 5
|
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CCNB1IP1
|
cyclin B1 interacting protein 1, E3 ubiquitin protein ligase
|
|
CDC42
|
cell division cycle 42
|
|
CDK11B
|
cyclin-dependent kinase 11B
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKL5
|
cyclin-dependent kinase-like 5
|
|
CDX2
|
caudal type homeobox 2
|
|
CHD5
|
chromodomain helicase DNA binding protein 5
|
|
CHD8
|
chromodomain helicase DNA binding protein 8
|
|
CIT
|
citron rho-interacting serine/threonine kinase
|
|
CLK2
|
CDC-like kinase 2
|
|
CLTCL1
|
clathrin, heavy chain-like 1
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSNK1G3
|
casein kinase 1, gamma 3
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
DBN1
|
drebrin 1
|
|
DDR2
|
discoidin domain receptor tyrosine kinase 2
|
|
DEK
|
DEK proto-oncogene
|
|
DFFB
|
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)
|
|
DGKB
|
diacylglycerol kinase, beta 90kDa
|
|
DIP2C
|
DIP2 disco-interacting protein 2 homolog C (Drosophila)
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOCK3
|
dedicator of cytokinesis 3
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD2
|
dopamine receptor D2
|
|
DST
|
dystonin
|
|
DYRK4
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4
|
|
ECM1
|
extracellular matrix protein 1
|
|
EEF2K
|
eukaryotic elongation factor 2 kinase
|
|
EIF2AK4
|
eukaryotic translation initiation factor 2 alpha kinase 4
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
EPHA6
|
EPH receptor A6
|
|
EPS15
|
epidermal growth factor receptor pathway substrate 15
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ETV1
|
ets variant 1
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCM
|
Fanconi anemia, complementation group M
|
|
FBN1
|
fibrillin 1
|
|
FHIT
|
fragile histidine triad
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FMO4
|
flavin containing monooxygenase 4
|
|
FN1
|
fibronectin 1
|
|
FNBP1
|
formin binding protein 1
|
|
FOXO1
|
forkhead box O1
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLTSCR1
|
glioma tumor suppressor candidate region gene 1
|
|
GMPS
|
guanine monphosphate synthase
|
|
GOLPH3
|
golgi phosphoprotein 3 (coat-protein)
|
|
GRIA3
|
glutamate receptor, ionotropic, AMPA 3
|
|
HAPLN1
|
hyaluronan and proteoglycan link protein 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC4
|
histone deacetylase 4
|
|
HERC2
|
HECT and RLD domain containing E3 ubiquitin protein ligase 2
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLF
|
hepatic leukemia factor
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HNF1A
|
HNF1 homeobox A
|
|
ILK
|
integrin-linked kinase
|
|
INHBA
|
inhibin, beta A
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB6
|
integrin, beta 6
|
|
ITPR2
|
inositol 1,4,5-trisphosphate receptor, type 2
|
|
JAG1
|
jagged 1
|
|
JUND
|
jun D proto-oncogene
|
|
KAT6B
|
K(lysine) acetyltransferase 6B
|
|
KAT7
|
K(lysine) acetyltransferase 7
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
|
KTN1
|
kinectin 1 (kinesin receptor)
|
|
LAMA1
|
laminin, alpha 1
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
LMTK2
|
lemur tyrosine kinase 2
|
|
LRP1B
|
low density lipoprotein receptor-related protein 1B
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MAML1
|
mastermind-like 1 (Drosophila)
|
|
MAML3
|
mastermind-like 3 (Drosophila)
|
|
MAP2K6
|
mitogen-activated protein kinase kinase 6
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPK10
|
mitogen-activated protein kinase 10
|
|
MAST3
|
microtubule associated serine/threonine kinase 3
|
|
MASTL
|
microtubule associated serine/threonine kinase-like
|
|
MCM4
|
minichromosome maintenance complex component 4
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MLH1
|
mutL homolog 1
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MSH6
|
mutS homolog 6
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYLK
|
myosin light chain kinase
|
|
NAV3
|
neuron navigator 3
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NEK1
|
NIMA-related kinase 1
|
|
NEK3
|
NIMA-related kinase 3
|
|
NLRP10
|
NLR family, pyrin domain containing 10
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NPAT
|
nuclear protein, ataxia-telangiectasia locus
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NPRL2
|
nitrogen permease regulator-like 2 (S. cerevisiae)
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NR2F1
|
nuclear receptor subfamily 2, group F, member 1
|
|
NUMA1
|
nuclear mitotic apparatus protein 1
|
|
NUP214
|
nucleoporin 214kDa
|
|
OBSCN
|
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
|
|
OMD
|
osteomodulin
|
|
OR2L13
|
olfactory receptor, family 2, subfamily L, member 13
|
|
PAX3
|
paired box 3
|
|
PBK
|
PDZ binding kinase
|
|
PCM1
|
pericentriolar material 1
|
|
PDE4DIP
|
phosphodiesterase 4D interacting protein
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
|
PIK3C2G
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma
|
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive)
|
|
PLCB2
|
phospholipase C, beta 2
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLK2
|
polo-like kinase 2
|
|
PLK4
|
polo-like kinase 4
|
|
PML
|
promyelocytic leukemia
|
|
PRCC
|
papillary renal cell carcinoma (translocation-associated)
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKD2
|
protein kinase D2
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PTCH1
|
patched 1
|
|
PTPRT
|
protein tyrosine phosphatase, receptor type, T
|
|
PTPRU
|
protein tyrosine phosphatase, receptor type, U
|
|
RABEP1
|
rabaptin, RAB GTPase binding effector protein 1
|
|
RAPGEF2
|
Rap guanine nucleotide exchange factor (GEF) 2
|
|
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1
|
|
RBL1
|
retinoblastoma-like 1
|
|
RECQL4
|
RecQ protein-like 4
|
|
REM1
|
RAS (RAD and GEM)-like GTP-binding 1
|
|
RIMS2
|
regulating synaptic membrane exocytosis 2
|
|
RIPK4
|
receptor-interacting serine-threonine kinase 4
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
ROBO2
|
roundabout, axon guidance receptor, homolog 2 (Drosophila)
|
|
RPL22
|
ribosomal protein L22
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RRM2
|
ribonucleotide reductase M2
|
|
SEMA3B
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
|
|
SGK2
|
serum/glucocorticoid regulated kinase 2
|
|
SKIL
|
SKI-like proto-oncogene
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC22A15
|
solute carrier family 22, member 15
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SMAD4
|
SMAD family member 4
|
|
SPP1
|
secreted phosphoprotein 1
|
|
STAG3
|
stromal antigen 3
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STK11
|
serine/threonine kinase 11
|
|
STK31
|
serine/threonine kinase 31
|
|
STK32A
|
serine/threonine kinase 32A
|
|
TBX18
|
T-box 18
|
|
TFR2
|
transferrin receptor 2
|
|
TG
|
thyroglobulin
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TMEM123
|
transmembrane protein 123
|
|
TNIK
|
TRAF2 and NCK interacting kinase
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TNN
|
tenascin N
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP63
|
tumor protein p63
|
|
TPM3
|
tropomyosin 3
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRIM33
|
tripartite motif containing 33
|
|
TTBK2
|
tau tubulin kinase 2
|
|
TTN
|
titin
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
ZNF331
|
zinc finger protein 331
|
|
ZNF608
|
zinc finger protein 608
|